Jim Simons Organogenesis Holdings Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 817,900 shares of ORGO stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

817,900

Previous 795,700 2.79%

Holding current value

$2.61 Million

Previous $2.23 Million 5.03%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.42 - $3.24 $53,724 - $71,928	22,200 Added 2.79%	817,900 $2.34 Million
Q2 2024 Aug 09, 2024	SELL	$2.28 - $3.03 $25,991 - $34,542	-11,400 Reduced 1.41%	795,700 $2.23 Million
Q1 2024 May 13, 2024	SELL	$2.61 - $4.49 $132,131 - $227,306	-50,625 Reduced 5.9%	807,100 $2.29 Million
Q4 2023 Feb 13, 2024	BUY	$1.97 - $4.21 $342,053 - $730,986	173,631 Added 25.38%	857,725 $3.51 Million
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $51,498 - $97,495	-22,008 Reduced 3.12%	684,094 $2.18 Million
Q2 2023 Aug 11, 2023	SELL	$1.9 - $4.3 $1.03 Million - $2.33 Million	-542,298 Reduced 43.44%	706,102 $2.34 Million
Q1 2023 May 12, 2023	BUY	$1.89 - $2.93 $141,753 - $219,755	75,002 Added 6.39%	1,248,400 $2.66 Million
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $23,812 - $32,934	-9,602 Reduced 0.81%	1,173,398 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $2.23 Million - $4.57 Million	710,800 Added 150.53%	1,183,000 $3.83 Million
Q2 2022 Aug 12, 2022	BUY	$4.74 - $8.15 $599,136 - $1.03 Million	126,400 Added 36.55%	472,200 $2.3 Million
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $1.42 Million - $2.11 Million	220,200 Added 175.32%	345,800 $2.64 Million
Q4 2021 Feb 11, 2022	SELL	$9.02 - $13.5 $2.2 Million - $3.29 Million	-244,000 Reduced 66.02%	125,600 $1.16 Million
Q3 2021 Nov 12, 2021	SELL	$13.71 - $17.18 $4.66 Million - $5.83 Million	-339,600 Reduced 47.88%	369,600 $5.26 Million
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $302,876 - $471,569	20,300 Added 2.95%	709,200 $11.8 Million
Q1 2021 May 13, 2021	BUY	$7.33 - $21.06 $312,258 - $897,156	42,600 Added 6.59%	688,900 $12.6 Million
Q4 2020 Feb 10, 2021	BUY	$3.63 - $7.53 $1.65 Million - $3.42 Million	454,500 Added 236.97%	646,300 $4.87 Million
Q3 2020 Nov 13, 2020	BUY	$3.29 - $4.58 $188,517 - $262,434	57,300 Added 42.6%	191,800 $737,000
Q2 2020 Aug 13, 2020	BUY	$2.86 - $4.61 $191,334 - $308,409	66,900 Added 98.96%	134,500 $516,000
Q1 2020 May 14, 2020	BUY	$2.92 - $5.31 $94,316 - $171,513	32,300 Added 91.5%	67,600 $218,000
Q4 2019 Feb 13, 2020	BUY	$4.7 - $8.11 $165,910 - $286,283	35,300 New	35,300 $170,000

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $418M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account